Cargando…

Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1

INTRODUCTION: Persistence of HIV‐1, causing chronic immune activation, is a key determinant of premature senescence. Early antiretroviral therapy (ART) has been associated with a reduced HIV‐1 reservoir in children with perinatally acquired HIV‐1 (PHIV), but its impact on the senescence process is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalzini, Annalisa, Ballin, Giovanni, Dominguez‐Rodriguez, Sara, Rojo, Pablo, Petrara, Maria Raffaella, Foster, Caroline, Cotugno, Nicola, Ruggiero, Alessandra, Nastouli, Eleni, Klein, Nigel, Rinaldi, Stefano, Pahwa, Savita, Rossi, Paolo, Giaquinto, Carlo, Palma, Paolo, De Rossi, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604380/
https://www.ncbi.nlm.nih.gov/pubmed/34797948
http://dx.doi.org/10.1002/jia2.25847
_version_ 1784601948203253760
author Dalzini, Annalisa
Ballin, Giovanni
Dominguez‐Rodriguez, Sara
Rojo, Pablo
Petrara, Maria Raffaella
Foster, Caroline
Cotugno, Nicola
Ruggiero, Alessandra
Nastouli, Eleni
Klein, Nigel
Rinaldi, Stefano
Pahwa, Savita
Rossi, Paolo
Giaquinto, Carlo
Palma, Paolo
De Rossi, Anita
author_facet Dalzini, Annalisa
Ballin, Giovanni
Dominguez‐Rodriguez, Sara
Rojo, Pablo
Petrara, Maria Raffaella
Foster, Caroline
Cotugno, Nicola
Ruggiero, Alessandra
Nastouli, Eleni
Klein, Nigel
Rinaldi, Stefano
Pahwa, Savita
Rossi, Paolo
Giaquinto, Carlo
Palma, Paolo
De Rossi, Anita
author_sort Dalzini, Annalisa
collection PubMed
description INTRODUCTION: Persistence of HIV‐1, causing chronic immune activation, is a key determinant of premature senescence. Early antiretroviral therapy (ART) has been associated with a reduced HIV‐1 reservoir in children with perinatally acquired HIV‐1 (PHIV), but its impact on the senescence process is an open question. We investigated the association between HIV‐1 reservoir and biological and immune ageing profile in PHIV enrolled in the multicentre cross‐sectional study CARMA (Child and Adolescent Reservoir Measurements on early suppressive ART) conducted within the EPIICAL (Early treated Perinatally HIV Infected individuals: Improving Children's Actual Life) consortium. METHODS: Between September 2017 and June 2018, CARMA enrolled 40 PHIV who started ART before 2 years of age and had undetectable viremia for at least 5 years before sampling date. Samples from 37 children with a median age of 13.8 years were available for this study. HIV‐1 DNA copies on CD4 cells, relative telomere length (marker of cellular senescence) and levels of T‐cell receptor rearrangement excision circle (TREC, marker of thymic output) on CD4 and CD8 cells were quantified by qPCR. Immunological profile was assessed by flow cytometry. Associations between molecular and phenotypic markers, HIV‐1 reservoir and age at ART initiation were explored using a multivariable Poisson regression. RESULTS: Higher HIV‐1 reservoir was associated (p<0.001) with telomere shortening (incidence rate ratio [IRR] = 0.15 [0.13–0.17]), immunosenescence (CD28(–)CD57(+), IRR = 1.23 [1.21–1.26]) and immunoactivation (CD38(+) HLADR(+), IRR = 7.29 [6.58–8.09]) of CD4 cells. Late ART initiation (after 6 months of age) correlated with higher HIV‐1 reservoir levels (552 [303–1001] vs. 89 [56–365] copies/10(6) CD4 cells, p = 0.003) and percentage of CD4 senescent cells (2.89 [1.95–6.31] vs. 1.02 [0.45–2.69, p = 0.047). TREC levels in CD8 cells were inversely associated with HIV‐1 reservoir (IRR = 0.77 [0.76–0.79]) and were significantly lower in late treated PHIV (1128 [486–1671] vs. 2278 [1425–3314], p = 0.042). CONCLUSIONS: Later ART initiation is associated with higher HIV‐1 reservoir size, which correlates with increased telomere shortening and senescence of CD4 cells. Timing of ART initiation in infancy has long‐term consequences on the immune and biological ageing profile of children with perinatally acquired HIV‐1.
format Online
Article
Text
id pubmed-8604380
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86043802021-11-24 Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1 Dalzini, Annalisa Ballin, Giovanni Dominguez‐Rodriguez, Sara Rojo, Pablo Petrara, Maria Raffaella Foster, Caroline Cotugno, Nicola Ruggiero, Alessandra Nastouli, Eleni Klein, Nigel Rinaldi, Stefano Pahwa, Savita Rossi, Paolo Giaquinto, Carlo Palma, Paolo De Rossi, Anita J Int AIDS Soc Research Articles INTRODUCTION: Persistence of HIV‐1, causing chronic immune activation, is a key determinant of premature senescence. Early antiretroviral therapy (ART) has been associated with a reduced HIV‐1 reservoir in children with perinatally acquired HIV‐1 (PHIV), but its impact on the senescence process is an open question. We investigated the association between HIV‐1 reservoir and biological and immune ageing profile in PHIV enrolled in the multicentre cross‐sectional study CARMA (Child and Adolescent Reservoir Measurements on early suppressive ART) conducted within the EPIICAL (Early treated Perinatally HIV Infected individuals: Improving Children's Actual Life) consortium. METHODS: Between September 2017 and June 2018, CARMA enrolled 40 PHIV who started ART before 2 years of age and had undetectable viremia for at least 5 years before sampling date. Samples from 37 children with a median age of 13.8 years were available for this study. HIV‐1 DNA copies on CD4 cells, relative telomere length (marker of cellular senescence) and levels of T‐cell receptor rearrangement excision circle (TREC, marker of thymic output) on CD4 and CD8 cells were quantified by qPCR. Immunological profile was assessed by flow cytometry. Associations between molecular and phenotypic markers, HIV‐1 reservoir and age at ART initiation were explored using a multivariable Poisson regression. RESULTS: Higher HIV‐1 reservoir was associated (p<0.001) with telomere shortening (incidence rate ratio [IRR] = 0.15 [0.13–0.17]), immunosenescence (CD28(–)CD57(+), IRR = 1.23 [1.21–1.26]) and immunoactivation (CD38(+) HLADR(+), IRR = 7.29 [6.58–8.09]) of CD4 cells. Late ART initiation (after 6 months of age) correlated with higher HIV‐1 reservoir levels (552 [303–1001] vs. 89 [56–365] copies/10(6) CD4 cells, p = 0.003) and percentage of CD4 senescent cells (2.89 [1.95–6.31] vs. 1.02 [0.45–2.69, p = 0.047). TREC levels in CD8 cells were inversely associated with HIV‐1 reservoir (IRR = 0.77 [0.76–0.79]) and were significantly lower in late treated PHIV (1128 [486–1671] vs. 2278 [1425–3314], p = 0.042). CONCLUSIONS: Later ART initiation is associated with higher HIV‐1 reservoir size, which correlates with increased telomere shortening and senescence of CD4 cells. Timing of ART initiation in infancy has long‐term consequences on the immune and biological ageing profile of children with perinatally acquired HIV‐1. John Wiley and Sons Inc. 2021-11-19 /pmc/articles/PMC8604380/ /pubmed/34797948 http://dx.doi.org/10.1002/jia2.25847 Text en © 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Dalzini, Annalisa
Ballin, Giovanni
Dominguez‐Rodriguez, Sara
Rojo, Pablo
Petrara, Maria Raffaella
Foster, Caroline
Cotugno, Nicola
Ruggiero, Alessandra
Nastouli, Eleni
Klein, Nigel
Rinaldi, Stefano
Pahwa, Savita
Rossi, Paolo
Giaquinto, Carlo
Palma, Paolo
De Rossi, Anita
Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1
title Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1
title_full Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1
title_fullStr Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1
title_full_unstemmed Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1
title_short Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1
title_sort size of hiv‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated european children with perinatally acquired hiv‐1
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604380/
https://www.ncbi.nlm.nih.gov/pubmed/34797948
http://dx.doi.org/10.1002/jia2.25847
work_keys_str_mv AT dalziniannalisa sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT ballingiovanni sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT dominguezrodriguezsara sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT rojopablo sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT petraramariaraffaella sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT fostercaroline sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT cotugnonicola sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT ruggieroalessandra sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT nastoulieleni sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT kleinnigel sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT rinaldistefano sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT pahwasavita sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT rossipaolo sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT giaquintocarlo sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT palmapaolo sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT derossianita sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1
AT sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1